日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H.

通过个性化的抗原非依赖性筛选方法鉴定的 T 细胞受体靶向共同的新抗原 KRAS Q61H

Lennerz Volker, Doppler Christoph, Fatho Martina, Dröge Anja, Schaper Sigrid, Gennermann Kristin, Genzel Nadine, Plassmann Stephanie, Weismann David, Lukowski Samuel W, Bents Dominik, Beushausen Christina, Kriese Karen, Herbst Hermann, Seitz Volkhard, Hammer Rudolf, Adam Paul J, Eggeling Stephan, Wölfel Catherine, Wölfel Thomas, Hennig Steffen

Evolution of melanoma cross-resistance to CD8(+) T cells and MAPK inhibition in the course of BRAFi treatment.

在 BRAFi 治疗过程中,黑色素瘤对 CD8(+) T 细胞和 MAPK 抑制剂的交叉耐药性演变

Pieper Natalia, Zaremba Anne, Leonardelli Sonia, Harbers Franziska Noelle, Schwamborn Marion, Lübcke Silke, Schrörs Barbara, Baingo Jolanthe, Schramm Alexander, Haferkamp Sebastian, Seifert Ulrike, Sucker Antje, Lennerz Volker, Wölfel Thomas, Schadendorf Dirk, Schilling Bastian, Paschen Annette, Zhao Fang

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

使用重组改良痘苗病毒安卡拉株 (MVA-hTyr) 对 II 期黑色素瘤患者进行酪氨酸酶 I 期疫苗接种研究

Meyer Ralf G, Britten Cedrik M, Siepmann Ulrike, Petzold Barbara, Sagban Tolga A, Lehr Hans A, Weigle Bernd, Schmitz Marc, Mateo Luis, Schmidt Burkhard, Bernhard Helga, Jakob Thilo, Hein Rüdiger, Schuler Gerold, Schuler-Thurner Beatrice, Wagner Stephan N, Drexler Ingo, Sutter Gerd, Arndtz Nathaly, Chaplin Paul, Metz Jost, Enk Alexander, Huber Christoph, Wölfel Thomas